Ansofaxine hydrochloride

CAS No. 916918-84-8

Ansofaxine hydrochloride( LY03005 | LPM570065 )

Catalog No. M20130 CAS No. 916918-84-8

Ansofaxine (LY03005; LPM570065) is a serotonin-norepinephrine-dopamine reuptake inhibitor (IC50s: 723 763 and 491 nM respectively).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 179 In Stock
5MG 163 In Stock
10MG 264 In Stock
25MG 511 In Stock
50MG 709 In Stock
100MG 918 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ansofaxine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Ansofaxine (LY03005; LPM570065) is a serotonin-norepinephrine-dopamine reuptake inhibitor (IC50s: 723 763 and 491 nM respectively).
  • Description
    Ansofaxine (LY03005; LPM570065) is a serotonin-norepinephrine-dopamine reuptake inhibitor (IC50s: 723 763 and 491 nM respectively).(In Vivo):Ansofaxine rapidly penetrates the rat striatum, converts into desvenlafaxine and exhibits larger total exposure compared with the administration of desvenlafaxine. Acute and chronic administration of oral suspension of ansofaxine increases the 5-HT, dopamine and norepinephrine levels more than the relative administration of desvenlafaxine. Unlike desvenlafaxine, acute administration of an intravenous ansofaxine solution does not induce the undesirable 90% decrease in extracellular 5-HT levels. The acute administration of ansofaxine shows a capped increase in extracellular 5-HT levels when combined with WAY-100635. Acute and chronic administration of ansofaxine reduces the immobility time more than the relative administration of desvenlafaxine.
  • In Vitro
    ——
  • In Vivo
    Ansofaxine rapidly penetrates the rat striatum, converts into desvenlafaxine and exhibits larger total exposure compared with the administration of desvenlafaxine. Acute and chronic administration of oral suspension of ansofaxine increases the 5-HT, dopamine and norepinephrine levels more than the relative administration of desvenlafaxine. Unlike desvenlafaxine, acute administration of an intravenous ansofaxine solution does not induce the undesirable 90% decrease in extracellular 5-HT levels. The acute administration of ansofaxine shows a capped increase in extracellular 5-HT levels when combined with WAY-100635. Acute and chronic administration of ansofaxine reduces the immobility time more than the relative administration of desvenlafaxine.
  • Synonyms
    LY03005 | LPM570065
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    serotonin reuptake| dopamine reuptake| norepinephrine reuptake
  • Research Area
    Neurological Disease
  • Indication
    Major depressive disorder

Chemical Information

  • CAS Number
    916918-84-8
  • Formula Weight
    417.97
  • Molecular Formula
    C24H32ClNO3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 30 mg/mL (71.77 mM)
  • SMILES
    Cl.CN(C)CC(c1ccc(OC(=O)c2ccc(C)cc2)cc1)C1(O)CCCCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhang R et al. The effects of LPM570065 a novel triple reuptake inhibitor on extracellular serotonin dopamineand norepinephrine levels in rats. PLoS One. 2014 Mar 10;9(3):e91775.
molnova catalog
related products
  • Alverine citrate

    Alverine Citrate(NSC35459) is a drug used for functional gastrointestinal disorders.

  • JWH-133

    JWH 133 is a potent CB2 selective agonist.

  • SB 742457

    SB742457 is a highly selective 5-HT6 receptor antagonist with pKi of 9.63.